Injectable calcium phosphate in the treatment of distal radial fractures

J Hand Surg Br. 1996 Dec;21(6):768-71. doi: 10.1016/s0266-7681(96)80184-7.

Abstract

An injectable material which hardened in situ to form a carbonated hydroxyapatite, Norian SRS (Norian Corp., Cupertino, USA), was used as the only treatment of unstable distal radial fractures in six patients. Except for an external dorsal splint for 2 weeks, no other treatment was used. The material maintained reduction except in one case in which there were technical problems during hardening and the material fragmented postoperatively. By 1 year all patients had a satisfactory clinical outcome. There was an early return of motion. The possibility of mobilization 1 or 2 weeks after the operation may reduce postoperative stiffness and increase short-term functional outcome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apatites
  • Bone Substitutes*
  • Calcium Phosphates / administration & dosage*
  • Follow-Up Studies
  • Fracture Healing / physiology
  • Humans
  • Injections
  • Postoperative Complications / diagnostic imaging
  • Pronation / physiology
  • Radiography
  • Radius Fractures / diagnostic imaging
  • Radius Fractures / surgery*
  • Range of Motion, Articular / physiology
  • Recurrence
  • Wrist Injuries / diagnostic imaging
  • Wrist Injuries / surgery*

Substances

  • Apatites
  • Bone Substitutes
  • Calcium Phosphates
  • alpha-tricalcium phosphate
  • tetracalcium phosphate
  • carboapatite
  • calcium phosphate, monobasic, anhydrous
  • calcium phosphate
  • calcium phosphate, dibasic, anhydrous